Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drug–Drug Interaction Potential of the HBV and HDV Entry Inhibitor Myrcludex B Assessed in vitro
Antje Blank, Katrin Meier, Stephan Urban, et al.
Antiviral Therapy (2017) Vol. 23, Iss. 3, pp. 267-275
Closed Access | Times Cited: 14

Showing 14 citing articles:

EASL Clinical Practice Guidelines on hepatitis delta virus
Maurizia Rossana Brunetto, G. Ricco, Francesco Negro, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 2, pp. 433-460
Open Access | Times Cited: 129
Assembly and infection efficacy of hepatitis B virus surface protein exchanges in 8 hepatitis D virus genotype isolates
Wenshi Wang, Florian A. Lempp, Franziska Schlund, et al.
Journal of Hepatology (2021) Vol. 75, Iss. 2, pp. 311-323
Open Access | Times Cited: 43
Virus entry and its inhibition to prevent and treat hepatitis B and hepatitis D virus infections
Thomas Tu, Stephan Urban
Current Opinion in Virology (2018) Vol. 30, pp. 68-79
Closed Access | Times Cited: 57
HBV/HDV Coinfection
Christopher Koh, Ben L. Da, Jeffrey S. Glenn
Clinics in Liver Disease (2019) Vol. 23, Iss. 3, pp. 557-572
Open Access | Times Cited: 50
Recent Advances in Hepatitis B Treatment
Georgia‐Myrto Prifti, Dimitrios Moianos, Erofili Giannakopoulou, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 5, pp. 417-417
Open Access | Times Cited: 38
Clinical Pharmacology of Bulevirtide: Focus on Known and Potential Drug–Drug Interactions
Martina Billi, Sara Soloperto, Stefano Bonora, et al.
Pharmaceutics (2025) Vol. 17, Iss. 2, pp. 250-250
Open Access
New therapies for hepatitis delta virus infection
Dimitri Loureiro, Corinne Castelnau, Issam Tout, et al.
Liver International (2021) Vol. 41, Iss. S1, pp. 30-37
Open Access | Times Cited: 22
Fluorescence-based methods for studying activity and drug-drug interactions of hepatic solute carrier and ATP binding cassette proteins involved in ADME-Tox
Csilla Özvegy‐Laczka, Orsolya Ungvári, Éva Bakos
Biochemical Pharmacology (2023) Vol. 209, pp. 115448-115448
Open Access | Times Cited: 8
Evaluation of the drug-drug interaction potential of the novel hepatitis B and D virus entry inhibitor bulevirtide at OATP1B in healthy volunteers
Vanessa Zhu, Jürgen Burhenne, Johanna Weiß, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 6
Antiviral Therapy of Chronic Hepatitis D Virus Infection – Addendum to the S3 Guideline “Prophylaxis, Diagnosis and Therapy of Hepatitis B Virus Infection” of the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS)
Lisa Sandmann, Thomas Berg, Katja Deterding, et al.
Zeitschrift für Gastroenterologie (2023) Vol. 61, Iss. 12, pp. e715-e732
Closed Access | Times Cited: 4
Metabolic Effect of Blocking Sodium-Taurocholate Co-Transporting Polypeptide in Hypercholesterolemic Humans with a Twelve-Week Course of Bulevirtide—An Exploratory Phase I Clinical Trial
Felicitas Stoll, Andrea Seidel-Glätzer, Ina Burghaus, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15924-15924
Open Access | Times Cited: 5
Addendum „Antivirale Therapie der chronischen Hepatitis-D-Virusinfektion“ zur S3-Leitlinie „Prophylaxe, Diagnostik und Therapie der Hepatitis-B-Virusinfektion“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS)
Lisa Sandmann, Thomas Berg, Katja Deterding, et al.
Zeitschrift für Gastroenterologie (2023) Vol. 61, Iss. 12, pp. 1635-1653
Open Access | Times Cited: 2
Hepatitis delta: recent advances and future therapies
Zillah Cargill, Ivana Carey, Kosh Agarwal
Future Virology (2024) Vol. 19, Iss. 5, pp. 215-223
Closed Access
A New Treatment for Chronic Hepatitis B and D Offers Novel Insights Into Obesity and Hepatic Steatosis
Robert Schierwagen, Sabine Klein, Jonel Trebicka
Cellular and Molecular Gastroenterology and Hepatology (2020) Vol. 10, Iss. 3, pp. 649-651
Open Access | Times Cited: 1
Page 1

Scroll to top